Oxford and GSK launch £50m programme to advance cancer research
Global biopharma company GSK invests up to £50 million in a collaboration with Oxford to advance the understanding of how cancer develops, which could inform future development of vaccines to prevent cancer.
Read moreLatest News
Sounds of Tolerance
4 June 2026
Upcoming Talks
Gene Transfer and Genome Editing of T cells for Cancer Immunotherapy
Thursday, 04 June 2026, 12pm to 1pm
Status: Cancelled
How does the Pseudomonas syringae cell envelope adapt to the plant microenvironment?
Thursday, 04 June 2026, 2pm to 3pm
Gene regulatory mechanisms of non-coding autoimmune risk loci in primary B cells
Friday, 05 June 2026, 9.15am to 10.15am
PEtab SciML: The missing layer for scalable and flexible scientific machine learning modeling in biology
Friday, 05 June 2026, 11am to 12pm
Dr Thomas Vogl- Center for Cancer Research at the Medical University of Vienna
Friday, 05 June 2026, 1pm to 2pm
Paul Ouwerkerk - The Oxford Variations
Monday, 08 June 2026 to Thursday, 31 December 2026, 9am - 5pm
Latest publications
DNA prime and peptide boost immunization elicits robust neoantigen-specific CD8 + T cell responses and therapeutic protection in mouse tumor models.
Journal article
Morgado-Cáceres P. et al, (2026), Oncoimmunology, 15
Systematic review and data-driven insights into CHO cell engineering for next-generation antibody production.
Journal article
Schulz A. et al, (2026), MAbs, 18
Ginkgo Datapoints Antibody Developability Competition outcomes: limited model performance and a call for data standardization.
Journal article
van Niekerk L. et al, (2026), MAbs, 18
Spatio-temporal eco-evolutionary dynamics of prey-predator systems with defended and undefended prey
Preprint
Roy S. et al, (2026)